N-METHYL-2-(4-NITRO-1H-PYRAZOL-1-YL)ACETAMIDE, 95.0%, 500mg

Tapón con vidrio marrón cónico estándar, vidrio DURAN®, semihueco, 29/32, 10 Unidad(es)

tert-Butyl (1,2,3,4-tetrahydroquinolin-6-yl)carbamate, 96%, 10g

(4-(sec-Butoxy)phenyl)methanol, 95.0%, 250mg

Fmoc-N-Me-Ala-OH, >98%, 100g

(S)-1-(4-(trifluoromethyl)phenyl)propan-1-amine, 95%, 1g

(4-(Pyridin-2-ylcarbamoyl)phenyl)boronic acid, 97.0%, 10g

Silica gel 60 C18 ec, 10 g

Ethyl 3-aminopyridazine-4-carboxylate, 95.0%, 1g

(R)-2-(DIMETHYLAMINOMETHYL)PYRROLIDINE 2HCL, 95.0%, 250mg

Methyl 3-Amino-5-cyanobenzoate, 98.0%, 250mg

Dimethyl itaconate, 98.0%, 25g

(R)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine, 95.0%, 1g